- A tumour is uncontrolled cell growth — benign tumours stay put; malignant ones invade tissue and metastasise.
- Cancer type is defined by the cells' origin: breast cancer that reaches the lungs is still breast cancer, not lung cancer.
- Metastatic cancer is the hardest to treat — early diagnosis and immune support matter most.
- Mushroom polysaccharides such as Lentinan are studied for stimulating macrophages and NK cells alongside conventional treatment.
What is a tumour?
A tumour is uncontrolled cell growth that forms a mass. Tumours are divided into benign and malignant. Benign tumours are not cancerous — they grow slowly and do not spread to other parts of the body. Malignant tumours are cancerous: they can invade surrounding tissue and reach other parts of the body through the blood or lymph. This process is called metastasis.
What is cancer?
Cancer is a disease caused by the uncontrolled multiplication and spread of altered cells. There are many types of cancer: breast, lung, colorectal, prostate, skin and many others. The type is determined by the original origin of the altered cells. For example, if breast cancer cells reach the lungs, the secondary tumour is still considered breast cancer, not lung cancer.
The difficulty of metastatic cancer
Metastatic cancer is one of the most difficult treatment challenges, because the disease has already spread to other parts of the body. Symptoms depend on the type of primary tumour and the location of the metastases, but most commonly include fatigue, weight loss and pain. Some cancers, such as skin cancer, are diagnosed more easily; others — such as bone cancer — are rarer and harder to manage. This is precisely why immune-system support is so important: a strong immune system can help recognise altered cells before they spread. A proper diet, reducing inflammation in the body, and supporting mitochondrial function are all factors we can control.
How cancer spreads through metastasis
Metastasis is the process by which cancer cells from the primary tumour reach another part of the body and form a secondary tumour there. The cells spread through the circulatory or lymphatic system. It is for this reason that early diagnosis and continuous immune-system support are so important.
Tumour treatment
Treatment depends on many factors, including the type of cancer, its location, size, and stage of spread. Methods may include:
- Surgery: depending on the cancer type, the tumour may be removed by operation, taking out the cancer cells and surrounding tissue areas. Minimally invasive surgical methods help reduce recovery time and the risk of complications.
- Radiotherapy: may be used together with surgery or chemotherapy. Advanced technologies allow this treatment to target tumour growth precisely. It uses X-rays and gamma rays.
- Chemotherapy and immunotherapy: systemic treatments used according to the cancer type and stage.
Fighting tumours: additional measures
It is worth knowing that alcohol can be a negative factor in fighting tumours, because it is toxic to cells. Alcohol use can worsen existing damage and have an undesirable effect, so avoiding it is advisable. It has long been known that mushrooms have an unmatched diversity of pharmacological properties and can be used as medicine. Lentinan is especially valued — this substance is widely studied and known for its anticancer properties. Acting through the immune system, Lentinan may stimulate immune cells such as cytokines, macrophages, and natural killer cells, which can help the body recognise and act on altered cells.
A strong immune system can help recognise altered cells before they spread. Mushroom polysaccharides are studied for their role in stimulating macrophages and NK cells.
Lentinan AXT by Zenius Labs™ →A tumour is an abnormal growth of cells in the body. Tumours can be benign (not dangerous) or malignant (cancerous). Malignant tumours can spread to other organs — this is called metastasis.
Yes. The immune system is the main defence against altered cells. Mushroom polysaccharides are studied for their role in activating NK cells and macrophages, which recognise and act on tumour cells. It is important to choose a concentrated multi-extract formula such as Lentinan AXT by Zenius Labs™.
A benign tumour grows slowly, does not spread to other organs, and is usually not life-threatening. A malignant tumour (cancer) grows faster, can invade surrounding tissue, and can metastasise — spreading through the blood or lymph to distant parts of the body.
Symptoms depend on the location and type. Common signs are an unexplained lump, unexplained weight loss, persistent fatigue, pain, and unusual bleeding. Regular preventive check-ups help diagnose tumours early.
Treatment depends on type, stage and location. The most common methods are surgery, chemotherapy, radiotherapy and immunotherapy. Immune-system support during and after treatment is very important for recovery.
- Antitumor polysaccharides from mushrooms: structural characteristics, antitumor mechanisms and immunomodulating activities. PubMed
- Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. PubMed
- Wang H et al. Efficacy of biological response modifier lentinan with chemotherapy for advanced cancer: a meta-analysis. Cancer medicine. 2017. PubMed
- Wang Y et al. Systematic review and meta-analysis on the efficacy and safety of Injectable Lentinan combined with chemotherapy in the treatment of gastric cancer. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024. PubMed
- Oba K et al. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer research. 2009. PubMed
- Gringhuis SI et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nature immunology. 2009. PubMed
- Jia XM et al. CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity. The Journal of experimental medicine. 2014. PubMed
- Cheng SC et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science (New York, N.Y.). 2014. PubMed
- Zhou G et al. Lentinan progress in inflammatory diseases and tumor diseases. European journal of medical research. 2024. PubMed
- Deng S et al. Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner. Journal of experimental & clinical cancer research : CR. 2018. PubMed
- You J et al. Lentinan induces apoptosis of mouse hepatocellular carcinoma cells through the EGR1/PTEN/AKT signaling axis. Oncology reports. 2023. PubMed
- Amino M et al. [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy. 1983. PubMed
- Zhen C et al. Comprehensive mechanisms and advanced delivery strategies of lentinan in antitumor therapy: A review. Colloids and surfaces. B, Biointerfaces. 2026. PubMed
- Chihara G Recent progress in immunopharmacology and therapeutic effects of polysaccharides. Developments in biological standardization. 1992. PubMed
- Oba K et al. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer immunology, immunotherapy : CII. 2007. PubMed
- Lu H et al. TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011. PubMed
- Engel AL et al. Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant. Immunobiology. 2013. PubMed
- Tanaka H et al. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer. Anticancer research. 2012. PubMed
- Chang Y et al. Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Discovery medicine. 2017. PubMed
- Standish LJ et al. Trametes versicolor mushroom immune therapy in breast cancer. Journal of the Society for Integrative Oncology. 2008. PubMed
- Kidd P Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Alternative medicine review : a journal of clinical therapeutic. 2011. PubMed
- Copat C et al. Astaxanthin in cancer therapy and prevention (Review). Biomedical reports. 2025. PubMed
- Li J et al. Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Κb P65 and Wnt/Β-Catenin in Vitro. Marine drugs. 2015. PubMed
- Lee J et al. Anti-Oxidant and Anti-Inflammatory Effects of Astaxanthin on Gastrointestinal Diseases. International journal of molecular sciences. 2022. PubMed
- Saini RK et al. Dietary carotenoids in cancer chemoprevention and chemotherapy: A review of emerging evidence. Pharmacological research. 2020. PubMed
- Geller AE et al. The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression. Nature communications. 2022. PubMed
- Dan A et al. Therapeutic Effects of Medicinal Mushrooms on Gastric, Breast, and Colorectal Cancer: A Scoping Review. Cureus. 2023. PubMed